Lantheus Holdings (LNTH) Return on Capital Employed Growth (1y) (2016 - 2026)
Lantheus Holdings (LNTH) Return on Capital Employed Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 89.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,195.00 |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | -1,072.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,072.00 |
| Dec 31, 2025 | -955.00 |
| Sep 30, 2025 | -2,091.00 |
| Jun 30, 2025 | -407.00 |
| Mar 31, 2025 | -639.00 |
| Dec 31, 2024 | -31.00 |
| Sep 30, 2024 | 3,527.00 |
| Jun 30, 2024 | 2,588.00 |
| Mar 31, 2024 | 3,498.00 |
| Dec 31, 2023 | 2,230.00 |
| Sep 30, 2023 | -1,664.00 |
| Jun 30, 2023 | -718.00 |
| Mar 31, 2023 | -60.00 |
| Dec 31, 2022 | 1,171.00 |
| Sep 30, 2022 | 2,442.00 |
| Jun 30, 2022 | 1,178.00 |
| Mar 31, 2022 | -297.00 |
| Dec 31, 2021 | -742.00 |
| Sep 30, 2021 | -445.00 |
| Jun 30, 2021 | -616.00 |